Liensinine
CAS: 2586-96-1
Ref. 3D-FL65625
5mg | 136,00 € | ||
10mg | 192,00 € | ||
25mg | 356,00 € | ||
50mg | 542,00 € | ||
100mg | 777,00 € |
Información del producto
- 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]phenol
- 4-[[(1R)-6,7-Dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol
- 4-{[(1R)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}phenol
- Phenol, 4-[(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]-2-[[1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-, [R-(R*,R*)]-
- Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-
Liensinine is a natural compound that has been shown to induce autophagy in an experimental model of oxidative injury. It has been found to inhibit the production of matrix metalloproteinases (MMPs) and cytokines, which are associated with cancer progression. Liensinine has also been shown to be an MMP-9 activity inhibitor and an inducer of autophagy. The molecular docking analysis demonstrated the binding of liensinine with autophagy inducer molecule, suggesting that it can be used as a therapeutic agent for various diseases such as cancer tissues or cellular physiology.
Propiedades químicas
Consulta técnica sobre: 3D-FL65625 Liensinine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.